Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

48,372 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48,372 results

Testing effectiveness (Phase 2)UnknownNCT03684863
What this trial is testing

Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Who this might be right for
HER2-positive Breast Cancer
Shandong Cancer Hospital and Institute 200
Not applicableActive Not RecruitingNCT05623787
What this trial is testing

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesAppendix Cancer+2 more
Laval University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Testing effectiveness (Phase 2)UnknownNCT00006114
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT05586516
What this trial is testing

Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
iOnctura 16
Testing effectiveness (Phase 2)Looking for participantsNCT06807606
What this trial is testing

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 35
Large-scale testing (Phase 3)Study completedNCT01097252
What this trial is testing

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancers
Korea Cancer Center Hospital 104
Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00990249
What this trial is testing

Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaAllogeneic Haematopoietic Stem Cell Transplantation+1 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)WithdrawnNCT02033538
What this trial is testing

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Zhejiang University
Testing effectiveness (Phase 2)Study completedNCT00887458
What this trial is testing

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Who this might be right for
Prostate Cancer
Johns Hopkins University 46
Large-scale testing (Phase 3)Study completedNCT01121848
What this trial is testing

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sanofi 108
Testing effectiveness (Phase 2)Ended earlyNCT00087048
What this trial is testing

Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 1
Not applicableLooking for participantsNCT02986048
What this trial is testing

Proton Therapy Patient Registry

Who this might be right for
Treatment With Proton Beam Radiation Therapy
Case Comprehensive Cancer Center 999
Not applicableEnded earlyNCT03197948
What this trial is testing

Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Early research (Phase 1)Study completedNCT00006485
What this trial is testing

Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02394015
What this trial is testing

Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC

Who this might be right for
Ovarian Epithelial Cancer Recurrent
Grupo Español de Investigación en Cáncer de Ovario 90
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableWithdrawnNCT07195617
What this trial is testing

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Next Page